Literature DB >> 7511719

Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist.

R Latini1, M Bianchi, E Correale, C A Dinarello, G Fantuzzi, C Fresco, A P Maggioni, M Mengozzi, S Romano, L Shapiro.   

Abstract

Cytokines play a pathogenetic role in a variety of infective and inflammatory diseases. In the present study, we had two objectives: (a) to define the kinetics of tumor necrosis factor (TNF) in plasma after acute myocardial infarction (AMI) in patients treated with early thrombolysis, and (b) to measure other cytokines, interleukin-1 (IL-1) and TNF receptor antagonists, in plasma. TNF-alpha, but not IL-1 beta or IL-8, was present in plasma of 6 of 7 patients with severe AMI (Killip class 3 or 4). No TNF (< 50 pg/ml) was detected in a group of 11 patients with uncomplicated myocardial infarction (Killip class 1) or in control patients without AMI. Soluble TNF receptor type I and IL-1 receptor antagonist (IL-1Ra) were also significantly increased in the group with severe AMI compared with those with uncomplicated AMI. Circulating TNF is increased only in AMI complicated by heart failure at hospital admission. This finding may have diagnostic and therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511719

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  16 in total

1.  Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.

Authors:  D Hasdai; M Scheinowitz; E Leibovitz; S Sclarovsky; M Eldar; V Barak
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 2.  Cardiotrophin-1 (CT-1): a novel hypertrophic and cardioprotective agent.

Authors:  D S Latchman
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

3.  Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function.

Authors:  N J Edmunds; H Lal; B Woodward
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

4.  Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.

Authors:  R J de Winter; A Manten; Y P de Jong; R Adams; S J van Deventer; K I Lie
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

5.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Authors:  K A Krown; M T Page; C Nguyen; D Zechner; V Gutierrez; K L Comstock; C C Glembotski; P J Quintana; R A Sabbadini
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

6.  Subchronic exposure of cardiomyocytes to low concentrations of tumor necrosis factor alpha attenuates the positive inotropic response not only to catecholamines but also to cardiac glycosides and high calcium concentrations.

Authors:  P Boekstegers; I Kainz; W Giehrl; W Peter; K Werdan
Journal:  Mol Cell Biochem       Date:  1996-03-23       Impact factor: 3.396

7.  Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.

Authors:  Harjot K Saini; Yan-Jun Xu; Ming Zhang; Peter P Liu; Lorrie A Kirshenbaum; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2005

8.  Maternal undernutrition induces differential cardiac gene expression in pulmonary hypertensive steers at high elevation.

Authors:  Hyungchul Han; Thomas R Hansen; Brynn Berg; Bret W Hess; Stephen P Ford
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

Review 9.  The role of IL-1 in the pathogenesis of heart disease.

Authors:  Marcin Bujak; Nikolaos G Frangogiannis
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-05-29       Impact factor: 4.291

10.  Tumor necrosis factor-alpha and mortality in heart failure: a community study.

Authors:  Shannon M Dunlay; Susan A Weston; Margaret M Redfield; Jill M Killian; Véronique L Roger
Journal:  Circulation       Date:  2008-07-21       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.